331.
|
mutliple drug resistance-1 {MDR-1} gene [bioch.] [gen./in¿.gen.] [biotech.] trafno¶æ: 5.9pkt.zaloguj siê |
332.
|
Self-emulsifying drug delivery systems {SEDDS} [farm.] trafno¶æ: 5.9pkt.zaloguj siê |
333.
|
skeletal drug delivery system [farm.] trafno¶æ: 5.9pkt.zaloguj siê |
334.
|
European Monitoring Centre for Drugs and Drug Addiction {EMCDDA} [og.] [toks.] trafno¶æ: 5.8pkt.zaloguj siê |
335.
|
Drug Rash with Eosinophila and Systemic Symptoms {DRESS} [farm.] [med.] [alerg/immun] trafno¶æ: 5.8pkt.zaloguj siê |
336.
|
United Nations Drug Control Programme {UNDCP} [og.] trafno¶æ: 5.8pkt.zaloguj siê |
337.
|
Drug Rash with Eosinophilia and Sytemic Symptoms – {DRESS} [med.] [derm./kosm.] [alerg/immun] trafno¶æ: 5.8pkt.zaloguj siê |
338.
|
Generalized bullous fixed drug eruption (GBFDE) [derm./kosm.] trafno¶æ: 5.8pkt.zaloguj siê |
339.
|
Collaboration Agreement between Drug Regulatory Authorities in European Union Associated Countries {CADREAC} [og.] [farm.] trafno¶æ: 5.6pkt.zaloguj siê |
340.
|
Hereditary haemolytic anaemia, unstable haemoglobin haemolytic disease
³ac.Anaemia haemolytica hereditaria, morbus haemolyticus cum haemoglobino instabili[med.] [hem.] trafno¶æ: 5.4pkt.zaloguj siê |
* Dok³adamy wszelkich starañ, aby wprowadzane przez nas has³a by³y poprawne. Jednak mimo weryfikacji, mog± pojawiæ siê b³êdy, za które wydawca nie bierze odpowiedzialno¶ci. Ka¿dy u¿ytkownik wykorzystuje has³a zawarte w s³owniku Verba Medica na w³asn± odpowiedzialno¶æ.